Hiroshi Moritake

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia

Masafumi Seki, Shunsuke Kimura, Tomoya Isobe et al. · Nature Genetics · 2017 · 133 citations

Medicine, Molecular Genetics, Oncology +15

Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase Activity

Megumi Funakoshi‐Tago, S. William Pelletier, Hiroshi Moritake et al. · Molecular and Cellular Biology · 2007 · 86 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia

Atsushi Narita, Hideki Muramatsu, Yumiko Sekiya et al. · Haematologica · 2015 · 73 citations · Full text

Medicine, Hematology, Pediatrics +16

Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome

Takashi Taga, Akiko Saito, Kazuko Kudo et al. · Blood · 2012 · 61 citations · Full text

Medicine, Hematology, Pediatrics +16

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Daisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe et al. · International Journal of Hematology · 2013 · 57 citations

Medicine, Oncology, Pediatrics +16